Yes. Companies that invest in drugs development deserve to make a profit. Patents protect their investment for a limited amount of time. They should not be able to make unlimited amounts of profit forever. What the drug price controls in Canada do is prevent a company from making a cosmetic change, like adding another stripe to the capsule of Losec, calling is Prilosec, and jacking up the price or increasing by 10 fold the price of an Epipen because you made a minor change to the delivery system. If there isn’t a proportionate increase in benefit to the patient you can’t raise the price in Canada.